Sangamo Biosciences (SGMO)

Sangamo Biosciences (SGMO) Stock Price & Analysis


SGMO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.58 - $6.42
Previous Close$1.74
Average Volume (3M)1.66M
Market Cap
Enterprise Value$58.64M
Total Cash (Recent Filing)$277.63M
Total Debt (Recent Filing)$43.11M
Price to Earnings (P/E)-1.4
May 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.24
Shares Outstanding192,903,474
10 Day Avg. Volume2,245,680
30 Day Avg. Volume1,662,846
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)1.55
Price to Sales (P/S)2.88
Price to Cash Flow (P/CF)11.50
P/FCF Ratio-1.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.53
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.32
Price Target Upside540.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Sangamo Biosciences’s price range in the past 12 months?
Sangamo Biosciences lowest stock price was $1.58 and its highest was $6.42 in the past 12 months.
    What is Sangamo Biosciences’s market cap?
    Currently, no data Available
    When is Sangamo Biosciences’s upcoming earnings report date?
    Sangamo Biosciences’s upcoming earnings report date is May 10, 2023 which is in 42 days.
      How were Sangamo Biosciences’s earnings last quarter?
      Sangamo Biosciences released its earnings results on Feb 22, 2023. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.36 by $0.04.
        Is Sangamo Biosciences overvalued?
        According to Wall Street analysts Sangamo Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Sangamo Biosciences pay dividends?
          Sangamo Biosciences does not currently pay dividends.
          What is Sangamo Biosciences’s EPS estimate?
          Sangamo Biosciences’s EPS estimate is -$0.33.
            How many shares outstanding does Sangamo Biosciences have?
            Sangamo Biosciences has 168,483,320 shares outstanding.
              What happened to Sangamo Biosciences’s price movement after its last earnings report?
              Sangamo Biosciences reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.36. Following the earnings report the stock price went up 0.344%.
                Which hedge fund is a major shareholder of Sangamo Biosciences?
                Among the largest hedge funds holding Sangamo Biosciences’s share is Caxton Associates LP. It holds Sangamo Biosciences’s shares valued at 518K.


                  Sangamo Biosciences Stock Smart Score

                  The Sangamo Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Sangamo Biosciences

                  Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.


                  Top 5 ETFs holding SGMO

                  Market Value
                  Smart Score
                  BMO MSCI Innovation Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold SGMO. The ETFs are listed according to market value of SGMO within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  HilleVax, Inc
                  Sorrento Therapeutics
                  Emergent Biosolutions
                  Intercept Pharma

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis